InventaBioTech Inc. (fka INVB)

[chemist72]

Thanks for the link. Financially INVB is a wreck.

From your link:

Inventa sells a device, the CytoPatch, for screening the safety and efficacy of drug formulations, and it also provides contract research services. Its contract research accounted for most of its revenue during the first three quarters of 2018: $562,000, according to a securities filing. Equipment sales totaled $188,000 during that period, the filing shows.

Most of those sales came during the third quarter of last year: about $582,000 in equipment and contract research sales took place in the three months that ended Sept. 30. The company recorded only $168,000 in revenue from equipment sales and contract research during the first half of the year, according to the securities filing. It ended the first nine months of 2018 with a $3.77 million net loss, the filing shows.

They also owe the city of San Antonio $400,000 according to the article that was linked in your post.

As far as I know this company has no employees. Where will the money come from to hire employees? Where are all their sales going to come from? This is almost as bad as owning a shell imho and no way to get out now with a bid price of $.033. I think we all got hoodwinked here. jmo

Not giving up yet but it really looks BAD to me.